Target intelligence / Profile preview

Extracellular vesicle uptake pathway (EV uptake)

Target
EV uptake
Molecular classification
Other
01

Overview

Extracellular vesicle (EV) uptake pathways refer to the collective biological processes by which recipient cells internalize membrane-bound vesicles, such as exosomes and microvesicles, to facilitate intercellular communication (Mulcahy et al., 2014, Journal of Extracellular Vesicles). These pathways are not defined by a single receptor but involve diverse mechanisms including clathrin-mediated endocytosis, caveolae-dependent endocytosis, macropinocytosis, phagocytosis, and direct plasma membrane fusion (van Niel et al., 2018, Nature Reviews Molecular Cell Biology). EVs serve as vehicles for the horizontal transfer of functional proteins, lipids, and various RNA species (mRNA, miRNA), which can significantly alter the physiological state of the recipient cell (Kalluri & LeBleu, 2020, Science). In pathological contexts, such as oncology, EV uptake is exploited by tumor cells to promote angiogenesis, remodel the extracellular matrix, and establish pre-metastatic niches. While these pathways are currently a major focus for developing targeted drug delivery systems, the lack of a single, universal uptake molecule makes them a complex and non-specific therapeutic target.

Other names
Exosome uptakeMicrovesicle internalizationEV-mediated cargo deliveryExtracellular vesicle endocytosis
02

Mechanism of action

Modulation of cellular internalization mechanisms, such as endocytosis or membrane fusion, to either inhibit the spread of pathological signals or facilitate the delivery of therapeutic cargo contained within vesicles.

03

Biological functions

Intercellular communicationSignal transductionCargo transportEndocytosis
04

Disease associations

CancerNeurodegenerative diseaseInflammationInfection
05

Safety considerations

Non-specific uptake by off-target cellsPotential immunogenicity of vesicle-associated proteinsRapid clearance by the mononuclear phagocyte systemHeterogeneity in vesicle size and cargo composition
06

Interacting drugs

Heparin

4 more in the full profile.

07

Biomarkers

CD63CD81CD9Tumor susceptibility gene 101 (TSG101)Programmed cell death 6-interacting protein (Alix)

Beyond the preview

Go deeper on Extracellular vesicle uptake pathway (EV uptake).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Extracellular vesicle uptake pathway (EV uptake).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call